Karolina Konstantynowicz-Nowicka

Arachidonic Acid as an Early Indicator of Inflammation during Non-Alcoholic Fatty Liver Disease Development

Klaudia Sztolsztener, Adrian Chabowski, Ewa Harasim‐Symbor et al. · Biomolecules · 2020 · 112 citations · Full text

Life Sciences, Biochemistry, Pathobiology +17

New Evidence for the Role of Ceramide in the Development of Hepatic Insulin Resistance

Karolina Konstantynowicz-Nowicka, Ewa Harasim‐Symbor, Marcin Baranowski et al. · PLoS ONE · 2015 · 62 citations · Full text

Life Sciences, Cell Biology, Endocrinology +17

Chronic Cannabidiol Administration Attenuates Skeletal Muscle De Novo Ceramide Synthesis Pathway and Related Metabolic Effects in a Rat Model of High-Fat Diet-Induced Obesity

Patrycja Bielawiec, Ewa Harasim‐Symbor, Karolina Konstantynowicz-Nowicka et al. · Biomolecules · 2020 · 29 citations · Full text

Life Sciences, Biochemistry, Pharmacology +15

Attenuation of Oxidative Stress and Inflammatory Response by Chronic Cannabidiol Administration Is Associated with Improved n-6/n-3 PUFA Ratio in the White and Red Skeletal Muscle in a Rat Model of High-Fat Diet-Induced Obesity

Patrycja Bielawiec, Ewa Harasim‐Symbor, Klaudia Sztolsztener et al. · Nutrients · 2021 · 29 citations · Full text

Life Sciences, Nutritional Sciences, Physiology +16

The effect of enterolactone on sphingolipid pathway and hepatic insulin resistance development in HepG2 cells

Tomasz Charytoniuk, Nicoletta Iłowska, Klaudia Berk et al. · Life Sciences · 2018 · 23 citations

Life Sciences, Biochemistry, Endocrinology +16